ARCHIVES

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

This article is from The Cancer Letter archive.

Vol. 23 No. 06 | February 14, 1997

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995

Abstracts From AACR Annual Meeting

May 28, 1976

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011